zzlangerhans’ Activity

Sun Nov 23

CAPS Underperform Pitch

zzlangerhans wrote about Novavax, Inc. (NVAX) . 10:40 AM

NVAX Underperform

I don't mind admitting that I don't really understand Novavax. All I know is that I've been following this company off and on for more than seven years and I've never even heard them discuss running a phase III trial. It just seems to be a [more]

Caps Pick

zzlangerhans made a pick in CAPS. 9:49 AM

Novavax, Inc. (NVAX) will Underperform the S&P 500

Fri Nov 21

CAPS Outperform Pitch

zzlangerhans wrote about Zogenix, Inc. (ZGNX) . 3:26 PM

ZGNX Outperform

I'm extending a very cautious outperform on Zogenix, a company I've trashed enthusiastically in the past. I still believe that their acetaminophen-free long acting hydrocodone Zohydro is doomed to failure, but the share price seems to have stabilized [more]

Caps Pick

zzlangerhans made a pick in CAPS. 2:13 PM

Zogenix, Inc. (ZGNX) will Outperform the S&P 500

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NBS. 10:12 AM

And my response to the NLM: Tony, I appreciate your elaborate response. I reviewed the reference you provided. It is difficult for me to read between the lines and understand why NLM permits an alteration in primary endpoint after unblinding of the [more]

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NBS. 9:39 AM

I received a response from the NLM, and I do have to give them credit for a personal and well-thought out response which I have copied below. I recommend that everyone review the short paper whose reference is provided at the end of the letter. The [more]

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NBS. 12:04 AM

No response yet, and it's clearly not a clerical error. It's a deliberate effort to obfuscate the failure of the trial. I'm not surprised to see this behavior from a scam biotech like NeoStem, but I think one has to draw a line when it comes to [more]

Thu Nov 20

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for RCPI. 12:50 PM

"wee confused" is an understatement.

Wed Nov 19

CAPS Underperform Pitch

zzlangerhans wrote about CELLCEUTIX CORP (CTIX) . 2:50 AM

CTIX Underperform

It's not easy to keep up with all the scams and cons in biopharma these days but every once in a while my kids actually go to sleep and don't wake up an hour later, and I have to make the most of it. Cellceutix is a fun one for several reasons, not [more]

CAPS Underperform Pitch

zzlangerhans wrote about Nymox Pharmaceutical Corp (NYMX) . 1:35 AM

NYMX Underperform

What's the point of coming back and giving Nymox one last kick in the teeth? I've already made my point about the futility of investing in this pathetic scam several times, and I was vindicated when the company finally reported failure of the phase [more]

Tue Nov 18

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NBS. 11:56 PM

The following is an e-mail I just sent to the Public Liaison Director at the National Library of Medicine, which administers the clinicaltrials website. Dear Ms. Cravedi, I am writing to inquire about a protocol change that I observed this morning in [more]

CAPS Outperform Pitch

zzlangerhans wrote about KITE PHARMA INC COM (KITE) . 11:53 PM

KITE Outperform

Welcome to the first piece of commentary about Kite Pharma ever written to contain no references whatsoever to flying, rising, becoming airborne, or any other similar pun related to the nature of kites. This 2014 IPO is priced as a legitimate [more]

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NBS. 10:57 AM

Incredibly, the clinicaltrials.gov entry for PreSERVE was just changed. Up until an hour ago, the primary endpoint on clinical trials.gov was written as: "To determine safety and the effect of intracoronary infusion of AMR-001 on myocardial [more]

CAPS Underperform Pitch

zzlangerhans wrote about Neostem, Inc. (NBS) . 9:52 AM

NBS Underperform

When I saw that NeoStem stock had jumped 20% and 5 strike November puts were selling for 40 cents yesterday ahead of the big PreSERVE reveal I couldn't believe my luck. There's little in the world of pharma to be more assured of than a fail of a [more]

Mon Nov 17

Caps Pick

zzlangerhans made a pick in CAPS. 10:43 AM

Neostem, Inc. (NBS) will Underperform the S&P 500

Fri Nov 14

Caps Pick

zzlangerhans made a pick in CAPS. 4:23 PM

Nymox Pharmaceutical Corp (NYMX) will Underperform the S&P 500

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for HTBX. 4:05 PM

Bought 2000 shares for zzporte at 4.45.

CAPS Underperform Pitch

zzlangerhans wrote about ZIOPHARM Oncology (ZIOP) . 4:05 PM

ZIOP Underperform

Ziopharm is up a decent chunk today, icing on the cake for anyone who found the stub tasty at October lows under 2.5. Nevertheless, I don't see this upswing carrying on past the company's presentations at AACR at the beginning of December. It seems [more]

Caps Pick

zzlangerhans made a pick in CAPS. 3:09 PM

ZIOPHARM Oncology (ZIOP) will Underperform the S&P 500

Thu Nov 13

Caps Pick

zzlangerhans made a pick in CAPS. 9:07 AM

KITE PHARMA INC COM (KITE) will Outperform the S&P 500
Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.85
Player Rank 112 out of 75066
Score 7949.61
Score Change Today -33.44
Accuracy 82.31%
Active Picks 155
Total Picks 1959
Best Pick SCTPF (+1627.06)
Worst Pick PCYC (-2886.09)
Average Score per Pick 4.06
Charms Earned 15
Highest Rated Favorite usubanas
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts